Central Trust Company’s Ironwood Pharmaceuticals IRWD Stock Holding History

Central Trust Company’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-48	Closed	-$1K	–	1358
2022 Q2	$1K	Hold	48	–	–	﹤0.01%	1299
2022 Q1	$0	Buy	+48	New	+$550	﹤0.01%	1417
2016 Q4	–	Sell	-1,194	Closed	-$16K	–	1181
2016 Q3	$16K	Hold	1,194	–	–	﹤0.01%	873
2016 Q2	$13K	Hold	1,194	–	–	﹤0.01%	929
2016 Q1	$11K	Hold	1,194	–	–	﹤0.01%	936
2015 Q4	$12K	Hold	1,194	–	–	﹤0.01%	945
2015 Q3	$10K	Hold	1,194	–	–	﹤0.01%	972
2015 Q2	$12K	Hold	1,194	–	–	﹤0.01%	968
2015 Q1	$16K	Hold	1,194	–	–	﹤0.01%	891
2014 Q4	$15K	Buy	1,194 +358	+43%	+$4.1K	﹤0.01%	901
2014 Q3	$9K	Hold	836	–	–	﹤0.01%	1001
2014 Q2	$11K	Buy	+836	New	+$9.09K	﹤0.01%	950

Other funds holding IRWD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Central Trust Company's IRWD Position: Q3 2022 in Review

Central Trust Company sold out of Ironwood Pharmaceuticals (IRWD) in Q3 2022, closing a stake of 48 shares — an estimated $1K sold.

Central Trust Company first reported a position in IRWD in Q2 2014 and held it in 12 quarters. The position peaked at $16K in Q3 2016. 245 funds tracked by Wall St. Rank hold IRWD as of Q3 2022.

Central Trust Company reported no remaining Ironwood Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
Central Trust Company sold 48 Ironwood Pharmaceuticals shares in Q3 2022, an estimated $1K.
Central Trust Company first reported a position in Ironwood Pharmaceuticals in Q2 2014 and held it in 12 quarters.
Central Trust Company's Ironwood Pharmaceuticals position peaked at $16K in Q3 2016.
245 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2022.

Based on Central Trust Company's 13F filing for Q3 2022, filed 3 Nov 2022.